Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
122 Cards in this Set
- Front
- Back
What are the Worm drugs that interfere w/ muscular activity?
|
niclosamide
praziquantal albendazole mebendazole thiabendazole diethylcarbamazine |
|
Niclosamide MOA?
|
Uncouples oxidative metabolism
Tapeworm scolex releases from the intestinal wall |
|
Praziquantal MOA?
|
opens calcium channels to cause muscular tetany
-- spastic paralysis -- causes tegmental damage which activates the host immune system |
|
Albendazole, Mebendazole MOA?
|
inhibits microtubules needed for glucose intake --> ↓ [glycogen] and [ATP] --> death
|
|
Thiabendazole MOA?
|
inhibits mitochondrial fumurate reductase
|
|
Diethylcarbamazine MOA?
|
Immobilizes microfilariae via decreased muscular activity
-- also alters surface membranes to make organism more susceptible to host immune defenses |
|
Worm drugs which interfere w/ synaptic transmission?
|
pyrantel pamoate
levamisole piperazine ivermectin |
|
Pyrantel pamoate, levamisole MOA?
|
ganglionic nicotinic cholinergic agonists = muscular tetany
|
|
Piperazine MOA?
|
a GABA agonist at chloride channel in NM jxn
-- flaccid muscle paralysis |
|
Ivermectin MOA?
|
releases GABA and ↑ GABA binding --> facilitate opening of chloride channels in NM junction
-- flaccid muscle paralysis in helminths, insects and ectoparasites -- may also cause tonic paralysis of musculature of nematodes via glutamate-gated Cl- channels found only in invertebrates Used a lot in the cow industry |
|
What are the WORM drugs?
|
Cestodes (tapeworms) – NICLOSAMIDE is DOC on exams
PRAZIQUANTAL is DOC in real world Third drug – MEBENDAZOLE |
|
Treatment of roundworms?
|
Ascaris lumbricoides
Albendazole Mebendazole Pyrantel pamoate Piperazine |
|
Treatment of pinworms?
|
Enterobius vermicularis
Mebendazole (a safety pin has a bend in it) Pyrantel pamoate |
|
Treatment of hookworms?
|
Necator americanus
Albendazole Mebendazole |
|
Treatment of whipworms?
|
Truchuris Trichuria
Albendazole Mebendazole |
|
Treatment of threadworms?
|
Strongyloides stercoralis
Ivermectin is the DOC Albendazole Thiabendazole |
|
Treatment of trichinosis?
|
Trichinella spiralis
Albendazole Mebendazole |
|
Treatment of filariasis?
|
Wucheria bancrofti
-- diethylcarbamazine Onchocerca volvulus -- Ivermectin is the DOC |
|
Other uses of ivermectin?
|
Tx of onchocerciasis and strongyloidasis (threadworm), ectoparasites
|
|
Treatment of trematodes?
|
(flukes) Schistosoma
Praziquantal is the DOC |
|
CLINICAL: Patient passes tape worm segments (proglottids) - most likely Taenia saginata (beef tapeworm) or a patient who likes to eat sushi passes tapeworm segments - most likely to be Diphyllobothrium latum (fish tapeworm) - treat with?
|
Niclosamide or Praziquantal
Fish tapeworm causes megaloblastic anemia because the worm takes up all the vitamin B12 in the gut Always worry that patient may have Taenia solium, pork tapeworm, which may produce cysticercosis (larval cysts) in the brain, orbit, muscles, liver and lungs. Tx cysticercosis w albendazole Praziqunatel is DOC if identity of the type of tapeworm is uncertain |
|
CLINICAL: Baby w anal itching (pruritis) and a postive “cellophane tape” test?
|
Pinworm infestation
Tx w/ mebendazole or pyrantel pamoate |
|
CLINICAL: Patient w mixed infestation = cestode (tapeworm) + trematode (fluke). Tx?
|
Mixed infestations treat w/ praziquantal
|
|
What are the antiprotozoal drugs?
|
Metronidazole
Pentamidine isethionate |
|
Metronidazole MOA?
|
Reduced to active nitroderivative that inhibits DNA replication
Active against anaerobic protozoa and bacteria |
|
Metronidazole is the DOC for?
|
Giardia lamblia
-- beaver fever -- camper’s fever Trichomonas -- trichomoniasis C Diff infections |
|
Metronidazole can also treat…?
|
Entamoiba histolytica (amebiasis)
Obligate anaerobic bacteria -- Bacteroides -- Clostridium difficile |
|
S/E’s of Metronidazole?
|
disulfiram-like rxn w/ EtOH headache, n/v, flushing
teratogenic |
|
MOA of Pentamidine isethionate?
|
Unknown
|
|
Therapeutic use of Pentamidine isethionate?
|
Second-line drug for PCP (Trim-sulfa is first)
-- use if pt can’t take sulfonamides |
|
What are the antimalarial drugs?
|
Primaquine
Chloroquine Mefloquine Sulfadoxine-Pyrimethamine |
|
Primaquine S/E’s?
|
Can cause acute hemolysis in pt w/ malaria in pts w/
-- glucose-6-phosphate dehydrogenase deficiency |
|
Chloroquine S/E’s?
|
Principal drawback is the wide-spread occurrence of resistance strains
tinnitus, headache |
|
Mefloquine is DOC for…?
|
prophylaxis for areas w/ chloroquine-resistant strains
|
|
Sulfadoxine-pyramethamine is DOC for…?
|
treatment of chloroquine-resistant malaria b/c it has a different MOA than chloroquine
|
|
Sulfadoxine MOA?
|
inhibits dihydropteroate synthase
|
|
Pyrimethamine MOA?
|
inhibits DHF reductase
-- can cause megaloblastic anemia |
|
What are the antiviral drugs?
|
Acyclovir
Ganciclovir Idoxuridine Amantadine Zanamivir Zidovudine Saquinavir Interferons |
|
Acyclovir MOA?
|
Converted to acyclovir-monophosphate by thymidine kinase.
Other enzymes convert it to acyclovir-triphosphate (acyclo-GTP) Inhibits viral DNA polymerase. |
|
Why isn’t acyclovir toxic to the host cells?
|
Mammalian cells phosphorylate acyclovir at 1/30-1/00 the rate of the HSV
Acyclo-GTP is 1/10-1/30 less active in inhibiting mammalian DNA polymerase |
|
Acyclovir is for treatment of…?
|
HSV
|
|
What causes HSV resistance to acyclovir?
|
a mutation which causes a deficiency of thymidine kinase
|
|
CASE: Immunocompromised patient w mucocutaneous HSV infection. Treatment?
|
Acyclovir
|
|
CASE: Patient w HSV encephalitis. Treatment?
|
Acyclovir
|
|
CASE: Patient w genital HSV infection. Treatment?
|
Acyclovir
|
|
Keratoconjunctivitus caused by HSV is treated with…?
|
Trifluridine (trifluorothymidine)
|
|
Ganciclovir MOA?
|
Phosphorylated to a triphosphate which inhibits DNA polymerase
-- triphosphate is a competitive substrate w deoxyguanosine triphosphate for incorporation into DNA Stops DNA chain elongation to inhibit DNA synthesis |
|
Ganciclovir is used to treat…?
|
Cytomegalovirus (CMV)
|
|
CASE: Immunocompromised patient w/ CMV infection. Treatment?
|
Ganciclovir
|
|
Idoxuridine MOA?
|
triphosphate inhibits viral DNA polymerase(resembles thymidine)
|
|
When HSV becomes resistant to idoxuridine, it will also be resistant to…?
|
trifluridine
B/C both drugs are thymidine derivatives which inhibit DNA polymerase |
|
Amantadine MOA?
|
Inhibits the membrane coat ion channel that allows the acid-mediated dissociation of ribonucleoprotein complex early in replication.
-- This inhibition of uncoating prevents the transfer of viral RNA into the cytoplasm of the mammalian cell |
|
Amantadine use?
|
Inhibits coating of influenza A and rubella viruses
Used prophylactically to prevent infection w/ influenza A |
|
Zanamivir MOA?
|
Inhibition of viral neuraminidase
|
|
Zanamivir therapeutic use?
|
Treatment of flu
|
|
Zidovudine MOA?
|
Converted to an active triphosphate which either
1. inhibits viral DNA polymerase (reverse transcriptase) OR 2. is incorporated into DNA in the place of thymidine to stop DNA chain elongation. |
|
Zidovudine therapeutic use?
|
AZT – HIV treatment
|
|
Zidovudine S/E’s?
|
bone marrow depression
anemia |
|
Saquinavir?
|
HIV protease inhibitor
Inhibit HIV aspartic protease which converts polyproteins into functional core proteins and viral enzymes |
|
Interferon MOA?
|
causes protein synthesis
1. 2,5 adenine synthetase -- makes adenylate oligomers which activate RNAase to degrade viral RNA 2. protein kinase phosphorylates elongation factor 2 to prevent peptide viral chain initiation 3. PDEase degrades terminal nucleotide of t-RNA to inhibit viral peptide chain elongation NET EFFECTS interferes w viral penetration, uncoating, assembly and release -- interferes w the synthesis of viral mRNA -- inhibition of the translation of viral mRNA |
|
What are the antifungal drugs?
|
Ampho B
Ketoconazole Flucytosine Trim Sulfa Griseofulvin |
|
Ampho B MOA?
|
Binds to ergosterol in fungal membranes to form pores
-- increases the permeability of the fungal membrane -- cells lose ions and macromolecules -- enhances penetration of other antifungal drugs such as flucytosine |
|
Ampho B resistance?
|
Decreased membrane ergosterol or altered structure of ergosterol
|
|
Ampho B therapeutic use?
|
DOC for
-- Coccidiodes immitis -- Aspergillis infections Also effective against Candida |
|
Ampho B S/E’s?
|
Clinical usefulness is limited by its nephrotoxicity
-- histological damage to renal tubules w cell necrosis -- renal tubular acidosis (a defect of renal function that produces systemic acidosis because bicarbonate ion cannot be reabsorbed in the PT or DT). -- hyperchloremic metabolic acidosis Renal toxicity can be avoided by giving mannitol to induce a high rate of urinary flow |
|
Ketoconazole MOA?
|
Inhibits fungal CYP450 which prevents the demethylation of lanosterol to ergosterol
-- so blocks cell wall synthesis All –konazoles have same MOA |
|
Therapeutic use of Ketoconazole?
|
Candida infections
Also effective against Coccidiodes immitis |
|
CLINICAL: Why is ketoconazole contraindicated in a patient receiving tx w amphoterecin B?
|
Because ketoconazole will BLOCK the antifungal actions of amphoterecin B
|
|
Ketoconazole and drug interactions?
|
Inhibits CYP450 to ↑ the plasma conc of other drugs
-- esp. cyclosporine in transplant patients (can damage kidneys) -- fluconazole also ↑ [cyclosporine] by MOA is unknown Inhibits adrenal 17 & scc CYP450’s -- adrenal insufficiency -- ↓ [testosterone] -- ↓ [estradiol] = gynecomastia -- ↓ libido & potency in males -- menstrual irregularities in females |
|
Flucytosine MOA?
|
converted to fluorouracil
-- inhibits thymidylate synthesis -- thus inhibits DNA synthesis |
|
Fungal resistance to Flucytosine?
|
Develops rapidly and limits its clinical effectiveness, so amphoterecin B is used to treat systemic fungal infections, or flucytosine and amphoterecin B are given together
Ampho B enhances penetration of flucytosine: synergistic antifungal activity |
|
Flucytosine S/E’s?
|
bone marrow depression
-- limits clinical usefulness |
|
CLINICAL: Which drug is selectively toxic to fungi because mammalian cells are unable to catalyze its deamination?
|
Flucytosine
|
|
Trim-sulfa is the DOC for…?
|
PCP (+ silver stain)
Secondary drug is pentamidine (espec if sulfa allergy) |
|
Griseofulvin MOA?
|
Disrupts mitotic spindle by interacting w polymerized microtubules
-- fungal mitosis is inhibited Inhibits fungal CYP450 to block synth of ergosterol |
|
Griseofulvin therapeutic use?
|
used to tx dermatophytes w hypae
-- Trichophyton -- Microsporum -- Epidermophyton. Can also tx athlete’s foot w miconazole DOC for ringworm on USMLE (in real world –conazole) |
|
PCN MOA?
|
interact w penicillin-binding proteins to inhibit transpeptidation and peptidoglycan synthesis
-- cell wall synthesis is inhibited |
|
PCN elimination?
|
Eliminated by renal tubular secretion.
-- Probenecid increases the half-life by inhibiting renal secretion (clearance). -- The [PCN] in serum ↑ whereas the [PCN] in the urine ↓ |
|
What can inhibit penicillinases (beta-lactamases)?
|
Clavulinate
Sulbactam Tazobactam |
|
Which PCNs are resistant to beta-lactamases?
|
Acid labile
-- methcillin -- nafcillin Acid stabile -- oxacillin -- cloxacillin -- dicloxacillin |
|
What is the primary beta-lactamase producing bacteria?
|
S. aureus
|
|
What else is resistant to beta-lactamases?
|
Imipenem/Cilastatin
-- resistant to beta-lactamase -- metabolized by renal tubular dihydropeptidases -- Cilastatin inhibits the renal peptidases to decrease renal clearance of imipenem to increase the half-life MOA -- block transpeptidase-dependent cross-linkage of peptidoglycan |
|
PCN S/E’s?
|
HSN rxns are common to all the PCNs
|
|
Cephalosporin MOA?
|
cef—
Have the same MOA as the PCNs 1st generation – very good MSSA and Strep coverage, OK community GNR 2nd generation – better Strep coverage, but worse Staph coverage -- better community GNR -- better anaerobic coverage 3rd generation -- G(+) coverage varies by drug -- all have improved GNR coverage -- some cover nosocomial GNR -- ALL penetrate CNS better than 1st or 2nd generation, and thus are preferred for meningitis |
|
CLINICAL: Patient w gonorrhea
|
Tx w penicillin for 8 weeks
|
|
CLINICAL: Patient returns with similar symptoms but no diplococci in urine (no longer has gonorrhea)
|
patient has Chlamydia infection
Tx w tetracycline unless patient is a PG female--then tx w erythromycin |
|
CLINICAL: Patient has Streptococcus infection and is allergic to PCNs. Tx?
|
Erythromycin (macrolide)
These others are better b/c they don’t cause diarrhea: -- Clarithromycin has better extracellular concentration -- Azithromycin |
|
Vancomycin MOA?
|
Bactericidal
Binds to 30S subunit -- interfere w/ initiation complex of peptide formation -- causes misreading of mRNA and break polysomes into non-functional monosomes. |
|
Vancomycin therapeutic use?
|
given i.v. for bacterial infections b/c not absorbed when given p.o
-- Serious life-threatening MRSA in the hospital -- If MSSA, can use any PCN -- outpatient, treat w/ trim-sulfa or clindamycin or doxycycline |
|
If C.diff occurs w/ i.v. vancomycin…?
|
P.O. vancomycin will still cure it (but want to limit p.o. use b/c this can cause resistance)
But DOC is metronidazole |
|
Aminoglycoside MOA?
|
Bactericidal
Binds to 30S subunit -- interfere w initiation complex of peptide formation -- causes misreading of mRNA and break polysomes into non-functional monosomes |
|
Aminoglycoside kinetics?
|
Decreased GFR increases the half-life of gentamicin
PCN’s enhance the cellular penetration of aminoglycosides = synergistic effects |
|
Aminoglycoside toxicity?
|
1. ototoxic
2. nephrotoxic, more so in elderly patients 3. drug accumulates in cells of PT and causes necrosis so urinary excretion of brush border enzymes increases -- effect usually reversible since cells of PT can regenerate 4. get defect of renal concentrating mechanism because gent acts on DT and CD to decrease the sensitivity to ADH 5. decreased GFR, mild proteinuria, hyaline and granular casts in urine NET EFFECT = mild increase in serum creatinine, hypokalemia, hypocalcemia and hypophosphatemia |
|
Trim-Sulfa MOA?
|
Bacteristatic
See pg 6 for schematic |
|
Trimethoprim – why doesn’t it affect humans?
|
100,000x more active against bacterial enzyme vs. mammalian enzyme
|
|
Trim-Sulfa therapeutic use?
|
Patient w/ AIDS develop infection w/ PCP – treat w/ trim sulfa
|
|
Trim-sulfa S/E’s?
|
Sulfonamides can displace bilirubin from plasma protein binding sites
Can cause kernicterus in neonates |
|
Tetracycline MOA?
|
Bacteriostatic
Bind to 30S subunit to block aminoacyl t-RNA binding to the acceptor (A) site |
|
Tetracycline therapeutic use?
|
Acts against gram (+) and (-) organisms, Rickettsiae, Mycoplasma, Chlamydia and amebas
NOT used for pneumococcal pneumonia -- tx w/ PCNs, Cephalosporins, or Erythromycin |
|
Tetracycline S/E’s?
|
Chelates Ca
-- adverse effect on formation of teeth and bones - fetus and babies -- bioavailability decreased by milk and food in GI tract Severe rash w/ sunlight |
|
Lincosamide MOA?
|
Lincosamide = Clindamycin
Bacteriostatic Binds to 50S subunit and blocks aminoacyl translocation of peptide chain |
|
Clindamycin therapeutic use?
|
First line for anaerobic coverage above the diaphragm
Second line for skin infections Good staph, strep coverage |
|
CLINICAL: You have treated a pt w/ clindamycin and they develop pseudomembraneous colitis. How do we treat this?
|
Tx w/ oral metronidazole (or oral vancomycin)
|
|
How do we treat TB?
|
RIPE
Rifampin (induces CYP450) Isoniazid Pyrazinamide Ethambutol |
|
Isoniazid S/E?
|
causes hepatic damage
|
|
Drugs which inhibit DNA gyrase?
|
nalidixic acid
FQ’s -- ciprofloxacin forms negative DNA supercoils |
|
What are the protein synthesis inhibitors?
|
buy AT 30, CELL at 50
A = aminoglycosides (cidal) + spectinomycin (static) – use for FCN resistant gonorrhea T = tetracyclines (static) C = chloramphenicol (static) E = erythromycin (static) L = lincomycin (static) L = cLindomycin (static) Since chloramphenicol, macrolides and clindamycin work at the same site, do NOT use them together because they will interfere w/ each other |
|
What are the bactericidal drugs?
|
PCNs, cephalosporins, aztreonam, imipenem
vancomycin bacitracin cycloserine aminoglycosides (gentimicin, etc) methenamine polymixin, colistin rifampin isoniazid FQ’s (norfloxacin, etc) nalidixic acid |
|
What are the bacteristatic drugs?
|
spectinomycin
chloramphenicol macrolides (erythromycin, etc) lincomycin clindamycin tetracyclines nitrofurans = nitrofurantoin sulfonamides/trimethoprim |
|
How is bacterial resistance usually acquired?
|
Plasmid-mediated resistance is easily transferred by transduction to other species of bacteria
|
|
What are the β-lactams?
|
PCNs
cephalosporins monobactans carbapenems The transpeptidase enzymes which are inhibited by the β-lactams are called penicillin-binding proteins (PBPs) because they are the target site for these drugs |
|
How do G (+) bugs become resistance to β-lactams?
|
1.production of bacterial β-lactamases (penicillinases)
2.altered PBP's with decreased affinity for β-lactams. Synthetic PCN's which are resistant to the β-lactamases may not be effective if if the bug also has altered PBP's 3. MRSA = mutations change the binding sites of the PBP = no β-lactam can bind to the PBP = MRSA is resistanct to all β-lactams (PCN's, cephs, imipenem, aztreonam) |
|
How do we treat MRSA?
|
Tx MRSA w clindmycin, trim-sulfa or possibly doxycycline
|
|
How do G(-) bugs become resistant to β-lactams?
|
1.production of bacterial β-lactamases (penicillinases) which may be inducible
2. reduced permeability --> β-lactams gain access to the periplasmic space (the site of the peptidoglycan wall in gram negative bugs) by passing through channels (called porins) in the outer bacterial membrane. -- A mutation which decreases the number of porins reduces the entry of the β-lactams to their site of action. -- Thus a β-lactam could resistant to β-lactamases, and yet not be able to inhibit bacteria growth because it could not reach the PBP's |
|
How do bugs become resistant to vancomycin?
|
VRE’s
Vancomycin inhibits cell wall synthesis by binding to the terminal D-ala of the nascent peptidoglycan side chain -- this action inhibits transglycosylation, so both the elongation and the cross-linking of the peptidoglycan chain are inhibited. Resistance occurs when a mutation changes the terminal D-ala to a D-lactate -- vancomycin can no longer bind |
|
How do bugs become resistant to FQs?
|
a single point mutation alters the binding of FQ's to the active site of DNA gyrase
|
|
How do bugs become resistant to aminoglycosides?
|
Aminoglycosides = gentamicin, tobramycin, amikacin
Plasmid-mediated enzymes are transferases which destroy the antibacterial effect of AG's by altering their structure The altered drug is inactive in inhibiting bacterial protein synthesis. Enzymatic alterations include acetylation of amine groups and phosphorylation of hydroxyl groups |
|
How do bugs become resistant to macrolides?
|
Macrolides = erythromycin, clarithromycin, azithromycin, clindamycin
bacterial enzymes methylate the 23S ribosomal component of the bacterial 50S ribosome This methylation prevents the binding of erthyromycin and clindamycin to the bacterial ribosome. |
|
How do bugs become resistant to tetracyclines?
|
tetracyclines = doxycycline
Pumped into susceptible bugs by an energy-dependent transport system in their cellular membranes. Plasmids carry resistance genes which decrease the intracellular accumulation and code for efflux pumps which extrude the drug from the cell |
|
How do bugs become resistant to folate synthesis inhibitors?
|
folate synthesis inhibitors = trim-sulfa
a plasmid-coded gene synthesizes a form of dihyropteroate synthetase which does not bind sulfonamides even though it still binds PABA Bacterial folate synthesis continues unabated |
|
How do drugs become resistant to rifampin?
|
A mutation causing a single amino acid substitution in the beta-subunit of the DNA-direcdted RNA polymerase reduces the binding of rifampin
|
|
How do drugs become resistant to chloramphenicol?
|
plasma mediated
Involves the production of acetyltransferases which inactivates the drug |